قالب وردپرس درنا توس
Home / Business / Regeneron stops its COVID-19 treatment trial for sick patients

Regeneron stops its COVID-19 treatment trial for sick patients



(Photo by David Ramos/Getty Images)

To the press room
Update 3:50 PM Pacific Time-Friday, October 30, 2020

For safety reasons, “Regeneron” has suspended trials on the most ill patients.

According to reports on Friday, the pharmaceutical company decided to stop providing antibody drugs to coronavirus patients on ventilators or patients receiving large amounts of oxygen.

However, the company said it will continue to conduct trials on patients with milder conditions.

This is after another pharmaceutical company, Eli Lilly, ended its trial on hospitalized patients on Monday after determining that the severe coronavirus was invalid.

More news: FBI hires external contractors to thoroughly check the use of FISA spy tools




Source link